Clinical Trial Update: COMparison Between All immunoTherapies for Multiple Sclerosis.

View source ↗

Summary

A completed clinical trial led by Karolinska Institutet comparing all immunotherapies for relapsing-remitting multiple sclerosis has posted results. The study (…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing-remitting Multiple Sclerosis

Snippet

Sponsor: Karolinska Institutet | Conditions: Relapsing-remitting Multiple Sclerosis | Status: COMPLETED | Results posted: 2025-04-20